Pharmaceutical
precision,
engineered
for forty-five
markets.
KP Life Science is a direct-from-India manufacturer of WHO-GMP certified generic medicines — shipping two hundred formulations, forty-five countries, under one regulatory file.
- 01 0+ Countries Served
- 02 0+ Products Portfolio
- 03 0+ Years Experience
- 04 0+ Global Clients
A direct manufacturer, not a trading intermediary.
Built on a single principle: what leaves Gujarat should arrive exactly as specified.
For sixteen years KP Life Science has operated as a direct-from-India manufacturer of generic pharmaceuticals. No middle layer, no re-labelling — each shipment traces back to a single WHO-GMP certified production floor.
Partners across forty-five markets rely on us for a specific reason: the documentation arrives complete, the batches arrive on time, and the specification never drifts between quote and container.
Formulations by therapeutic area
Two hundred SKUs, organised the way regulatory filings want them.
- 01
Analgesics
Pain relief medicines for acute and chronic pain management.
View products - 02
Antipyretics
Fever-reducing medicines for effective temperature control.
View products - 03
Antibiotics
Broad-spectrum antibiotics to treat bacterial infections.
View products - 04
Antifungal
Medicines to treat fungal infections across various sites.
View products - 05
Antiviral
Antiviral agents to treat viral infections effectively.
View products - 06
Antimalarial
Effective antimalarial drugs for prevention and treatment of malaria.
View products - 07
Antidiabetic
Medicines to control blood sugar levels in diabetic patients.
View products - 08
Cardiovascular
Heart and blood pressure medicines for cardiovascular health.
View products - 09
Gastrointestinal (GI)
Stomach and digestion medicines including antacids and proton pump inhibitors.
View products - 10
Respiratory
Asthma and breathing medicines for respiratory conditions.
View products - 11
Antihistamines / Anti-allergic
Allergy treatment medicines for effective symptom relief.
View products - 12
Dermatology
Skin medicines for treating various dermatological conditions.
View products - 13
Neurology / CNS
Brain and nervous system medicines for neurological disorders.
View products - 14
Gynecology
Women's health medicines for gynecological care.
View products - 15
Urology
Urinary system medicines for urological conditions.
View products - 16
Orthopedic
Bone and joint medicines for musculoskeletal health.
View products - 17
Ophthalmology
Eye medicines for various ophthalmic conditions.
View products - 18
ENT
Ear, nose, and throat medicines for ENT conditions.
View products - 19
Vitamins & Nutritional Supplements
Health supplements including vitamins, minerals, and nutraceuticals.
View products - 20
Oncology
Cancer treatment medicines and supportive care products.
View products - 21
Surgicals & Disposables
Surgical instruments, equipment, and single-use medical disposables for clinical use.
View products
Why partners work with us
Four disciplines. Repeated reliably, shipment after shipment.
- 01
Quality assurance
Every batch is tested in-house against USP, BP, and IP standards before release. GLP-certified laboratory. Retained samples for the full shelf life.
- 02
Regulatory dossiers
Certificate of Analysis, Certificate of Origin, BSE/TSE declarations, and country-specific regulatory files prepared to match the import market.
- 03
Supply logistics
Temperature-controlled shipping, customs documentation, and delivery in 45+ markets. FOB, CIF, or DDP depending on the route and counterparty.
- 04
Direct pricing
Manufacturer-to-buyer, no intermediaries and no re-labelling margins. Quoted pricing holds for the quarter on indicative volumes.
Distribution footprint
One manufacturing file,
forty-five import markets.
Shipments leave a single WHO-GMP facility in Surat, Gujarat and clear customs in forty-five countries against regulatory files prepared for each market.
- 01 Africa 20+
- 02 South East Asia 10+
- 03 Latin America 8+
- 04 Middle East 5+
- 05 CIS 3+
Field notes from the export desk.
- 01 08 APR 2026Industry Insights
The GLP-1 Crisis: How Ozempic and Mounjaro Shortages are Reshaping Pharmaceutical Supply Chains
Global demand for semaglutide and tirzepatide has outstripped supply, creating unprecedented shortages. We examine what this means for API manufacturers, exporters, and the future of GLP-1 drug production.
- 02 02 APR 2026Market Intelligence
Biosimilar GLP-1 Drugs: A Massive Opportunity for Indian Pharmaceutical Exporters
As GLP-1 receptor agonist patents near expiration, Indian pharma companies are positioned to lead the biosimilar wave. Explore the regulatory pathway, API sourcing strategies, and market potential.
- 03 01 MAR 2026Market Intelligence
Complete Guide to Pharmaceutical Exports from India in 2026
India is the world's largest provider of generic medicines, supplying over 50% of global demand. Learn how to navigate the export landscape.
- 04 15 FEB 2026Regulatory & Compliance
WHO-GMP Certification: Requirements and Benefits for Pharma Exporters
Understanding WHO-GMP certification is crucial for pharmaceutical companies looking to export to regulated markets worldwide.
Send a specification.
We’ll return a quote.
Share the molecule, dosage, pack size, and destination market. Our export desk will respond with pricing, documentation timelines, and the earliest available shipping window.